Abstracts and Articles

HE

The summaries are free for public use. The Chronic Liver Disease Foundation will continue to add and archive summaries of articles deemed relevant to CLDF by the Board of Trustees and its Advisors.

1 11/07/2025

Citizen science in osteoarthritis research: a scoping review.

Rucci Massimiliano (M);Caldo Davide (D);Ferracini Riccardo (R)

2 11/07/2025

Anti-seizure medications in patients with post-stroke epilepsy: A survival analysis study.

Antonazzo Ippazio Cosimo (IC);Fornari Carla (C);Buongarzone Gabriele (G);Ferrara Pietro (P);Crotti Giacomo (G);Zucchi Alberto (A);Cortesi Paolo Angelo (PA);Rozza Davide (D);Mantovani Lorenzo Giovanni (LG);Mazzaglia Giampiero (G)

3 11/06/2025

Use of Natural language processing to objectively identify hepatic encephalopathy in multiple cohorts.

Silvey Scott (S);Patel Nilang (N);Davis Brian C (BC);Sterling Richard K (RK);Aljabi Anas (A);Shenoy Abhishek (A);Puri Puneet (P);Fuchs Michael (M);Bush Brian J (BJ);Bajaj Jasmohan S (JS)

4 11/05/2025

Human Albumin infusion in liver Cirrhosis and overt Hepatic Encephalopathy (HACHE): protocol of an investigator-initiated, open-label, multicentre, randomised controlled trial.

Li Qianqian (Q);Tong Huan (H);Liu Xuemei (X);Liao Fei (F);Ma Han (H);Zhou Zhihang (Z);Liu Fei (F);Shi Haitao (H);Wang Zhongfeng (Z);Sun Yang (Y);Yao Qunyan (Q);Feng Yan (Y);Li Ximei (X);Feng Jing (J);He Zhoutao (Z);Peng Ya (Y);Bai Zhaohui (Z);Zhu Rong (R);Cheng Du (D);Xu Chengfu (C);He Song (S);Yu Huihong (H);Xie Chen (C);Yuan Jia (J);Wang Xinrui (X);Yang Hongju (H);Zou Yanting (Y);Li Shuyu (S);Li Ting (T);Hu Shengjuan (S);Chen Chaochao (C);Chen Zhiyuan (Z);Lantinga Marten A (MA);Bernardi Mauro (M);Qi Xingshun (X);Tang Chengwei (C); ()

5 11/04/2025

To select or not to select: evaluating the effectiveness of SeLECT score in predicting the risk of post-stroke seizures: a systematic review.

Ayaz Ahmed (A);Hashmi Syeda Amrah (SA);Ibrahim Muhammad (M);Sharma Sameer (S);Abbas Muhammad Asjad (MA);Zawar Ifrah (I)

6 11/04/2025

Palovarotene for patients with multiple hereditary exostosis: results of MO-Ped, a terminated, randomized, placebo-controlled, double-blind phase 2 trial.

Sangiorgi Luca (L);Conrad Ernest U (EU);Shih Fei (F);Strahs Andrew (A);Feldman David S (DS)

7 11/04/2025

Predictive value of neutrophil to lymphocyte ratio for clinical outcomes in liver cirrhosis: A systematic review and meta-analysis.

Lin Jingjing (J);Huang Mengna (M);Shen Lina (L)

8 11/01/2025

Transcriptomic signatures of gray matter volume alterations in hepatic encephalopathy.

Huang Chu-Xin (CX);Liu Jun (J)

9 10/30/2025

Long-term albumin treatment for decompensated cirrhosis in Italy: A propensity score-matched, retrospective, real-world chart analysis.

Laleman Wim (W);Trebicka Jonel (J);O'Brien Alastair (A);Zaccherini Giacomo (G);Caraceni Paolo (P);Rodrigues Joana F (JF);Zhang Xiang (X);Kelly Maebh (M);Rodney Kyle (K);Schweiger Sofia (S);Angeli Paolo (P)

10 10/30/2025

Therapeutic plasma exchange in amatoxin associated acute liver failure-results from the multi-center Amanita-PEX study.

Stahl Klaus (K);Nalbant Bahar (B);Pape Thorben (T);Breteau Isaure (I);Coirier Valentin (V);Cardoso Filipe S (FS);de Haan Jubi (J);Janik Maciej K (MK);Wasmuth Jan-Christian (JC);Madaleno João (J);Merle Uta (U);Frohme Josephine (J);Tepasse Phil-Robin (PR);Müller Martina (M);Große Karsten (K);Linke Alexandra (A);Mareljic Nikola (N);Larsen Fin Stolze (FS);Dahlqvist Gérladine (G);Kolev Mirjam (M);Schulze Marie (M);Willuweit Katharina (K);Janke-Maier Petra (P);Dondorf Felix (F);Fierro-Angulo Óscar M (ÓM);Geerts Anja (A);Toapanta David (D);Dejean Camille (C);Alharthi Mohamed (M);Reverter Enric (E);Schenk Heiko (H);Raevens Sarah (S);Macías-Rodríguez Ricardo Ulises (RU);Rauchfuß Falk (F);Berg Christoph P (CP);Schmidt Hartmut (H);Geier Andreas (A);Semmo Nasser (N);Lanthier Nicolas (N);Bjerring Peter N (PN);Lange Christian M (CM);Sterneck Martina (M);Bruns Tony (T);Schmid Stephan (S);van de Loo Dominik (D);Demir Münevver (M);Boettler Tobias (T);Borges Catarina (C);Nattermann Jacob (J);Wronka Karolina (K);den Hoed Caroline M (CM);Marques Hugo P (HP);Artru Florent (F);Levesque Eric (E);Wedemeyer Heiner (H);Campos-Murguia Alejandro (A);Taubert Richard (R); ()

11 10/28/2025

Efficacy and Safety of Spontaneous Portosystemic Shunts Embolization for Hepatic Encephalopathy: A Meta-analysis.

Wang Xing (X);Wang Zhengyu (Z);Luo Bohan (B);Lv Yong (Y);Han Guohong (G)

12 10/27/2025

Clinical Outcomes of Intravenous Albumin Administration After Acute Variceal Hemorrhage in Patients with Cirrhosis: An Open-Label, Randomized Controlled Trial.

Biswas Sagnik (S);Mehta Shubham (S);Swaroop Shekhar (S);Aggarwal Arnav (A);Agarwal Ayush (A);Saxena Sarthak (S);Agarwal Samagra (S);Gupta Sanchita (S);Gamanagatti Shivanand (S);Shalimar ()

13 10/26/2025

Body mass index and its association with clinical outcomes in acute liver failure.

Krishnan Arunkumar (A);Khan Sameer (S);Gips Julia (J);Alqahtani Saleh A (SA);Vaidya Dhananjay (D);Liu Yi-Si (YS);Kim Ahyoung (A);Su Amanda (A);Gurakar Ahmet (A);Hamilton James P (JP);Woreta Tinsay A (TA)

14 10/23/2025

Proton pump inhibitors do not impact on the severity and mortality of the acute-on-chronic liver failure ‒ Andalusian multicentric prospective study.

García-Gavilán María Del Carmen (MDC);Guerrero-Misas Marta (M);García-García Alberto Manuel (AM);Casado-Martín Marta (M);Castillo-Molina Laura (L);Sánchez-Torrijos Yolanda (Y);Sendra Carmen (C);Rivas Ruiz Francisco (F);Rosales-Zábal José Miguel (JM)

15 10/22/2025

First Latin American consensus on the treatment and prophylaxis of hepatic encephalopathy.

Higuera-de-la-Tijera Fátima (F);Alvares-da-Silva Mario Reis (MR);Castro-Narro Graciela Elia (GE);Barahona-Garrido Josué (J);Carrera-Estupiñán Enrique (E);Garavito-Rentería Jorge (J);Henríquez-Meléndez Héctor Adolfo (HA);Cely Geovanny Hernández (GH);Mora-Lazo Javier (J);Mendizabal Manuel (M);Mezzano-Puentes Gabriel Alejandro (GA);Oliveira Claudia P (CP);Guimarães Pessoa Mário (M);Suárez-Quintero Yanette (Y);Velasco José Antonio Velarde-Ruiz (JAV)

16 10/21/2025

Mortality risk prediction in liver transplant candidates: a prognostic model using key clinical variables.

Aghazadeh Mohammad Hossein (MH);Azizmohammad Looha Mehdi (M);Khaleghjoo Yadmehr (Y);Ghoorchi Beigi Fatemeh (F);Rabbani Amirhassan (A);Parsa Tina (T);Parsa Yekta (Y)

17 10/17/2025

Lactulose, Rifaximin, and Survival in Hepatic Encephalopathy: A Cohort Study of 120 Patients.

Alexandrescu Luana (L);Tofolean Ionut Tiberiu (IT);Aftenie Cristina (C);Alexandrescu Daria Maria (DM);Tofolean Doina Ecaterina (DE);Nicoara Alina Doina (AD);Stanigut Alina Mihaela (AM);Nelson Twakor Andreea (A);Rusu Elena (E);Dumitru Eugen (E);Dumitru Andrei (A);Tocia Cristina (C);Herlo Alexandra (A);Mihu Miruna Alexa (MA);Popescu Ioana (I);Dina Elena (E);Cimpineanu Bogdan (B)

18 10/17/2025

Development of overt hepatic encephalopathy increases mortality in patients with cirrhosis: a multicenter retrospective cohort study.

Iwasa Taisei (T);Miwa Takao (T);Utakata Yuki (Y);Oi Mikita (M);Asakura Mayu (M);Onishi Takumi (T);Aiba Masashi (M);Unome Shinji (S);Hanai Tatsunori (T);Shiraki Makoto (M);Adachi Seiji (S);Katsumura Naoki (N);Kawashima Yasuhiro (Y);Nishiwaki Shinji (S);Shimizu Masahito (M)